Skip to main content

Correction to: Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells

The Original Article was published on 03 May 2019

Correction to: J Exp Clin Cancer Res (2019) 38:184

https://doi.org/10.1186/s13046-019-1173-4

In the original publication of this article [1], there are two errors.

The first error is in author affiliation information. The corrected author affiliation information is as given hereafter:

Xihong Liu1, Peiyuan Zhao4, Xiujuan Wang1*, Lei Wang1, Yingjun Zhu1, Yadi Song1 and Wei Gao1,2,3*.

1 School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.

2 School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.

3 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.

4 Basic Discipline of Integrated Chinese and Western Medicine, Henan University of Chinese Medicine, Henan, China.

The second error is in Fig. 8d (panel 2 of Tunel assay, group of 1 mg/kg Cel). The revised Fig. 8 which includes 8d has now been included in this correction.

Fig. 8
figure 1

Celastrol suppressed the growth of orthotopic xenografts of U251 cells in vivo. a One week after inoculation, MRI scanning of glioma was performed on a 7.0 T MR scanner. b One week after inoculation, H&E staining of tumor tissue was carried out. Scale bars = 50 μm (c) Tumor volumes determined by MRI at 0, 7 and 14 days after inoculation in the 5 different groups. d Tunel assay and immunohistochemical staining of tumor specimens. Scale bars = 50 μm. e The levels of cleaved caspase-3, LC3B, p-JNK, p-Akt and p-mTOR in tumor tissues were detected by western blotting. β-actin was used as an internal control. Data are presented as the Mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, significantly different compared with the untreated control group

The correct Fig. 8 is given hereafter:

The error: In the initially published version of this article, the picture in the Tunel assay of Cel (1 kg/mg) group are the same with that in Cel (2 kg/mg) group in Fig. 8d.

This error does not affect discussions and conclusions drawn in the article.

Reference

  1. Liu X, et al. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38:184.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiujuan Wang or Wei Gao.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Zhao, P., Wang, X. et al. Correction to: Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res 38, 284 (2019). https://doi.org/10.1186/s13046-019-1285-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-019-1285-x